{"nct_id":"NCT05552976","title":"A Study to Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2023-01-10","start_date_type":"ACTUAL","primary_completion_date":"2026-02-04","primary_completion_date_type":"ESTIMATED","completion_date":"2029-07-25","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["BMY"]}